TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nanologica AB ( (SE:NICA) ) has shared an update.
Nanologica AB’s independent bid committee has received a Fairness Opinion from Redeye AB regarding a public takeover offer from Flerie AB. The opinion concludes that the offer, valued at approximately 88.8 million kronor, is not financially reasonable for Nanologica’s shareholders. This assessment may impact the company’s strategic decisions and influence shareholder perspectives on the takeover bid.
More about Nanologica AB
Nanologica AB operates in the biotechnology industry, focusing on the development and commercialization of nanoporous silica for drug delivery and chromatography applications. The company aims to enhance drug formulation and improve the efficiency of pharmaceutical processes.
Average Trading Volume: 347,622
Current Market Cap: SEK97.63M
See more insights into NICA stock on TipRanks’ Stock Analysis page.